Abstract
Colon cancer is the third most frequently occurring and second most deathcausing disease in the entire world. Even though there is rapid development in the
treatment, there is a high increase in the death rate of colon cancer. The current
treatments available for colon cancer are not specific and are mainly associated with
numerous toxic effects. Hence, developing novel drug treatments with desired
characteristics to treat colon cancer patients is in huge demand. In case of novel drug
discovery for various kinds of dreadful diseases like cancer and neurodegenerative
diseases, medicinal and plant-derived components also play a significant role. Here, in
this review, we have chosen andrographolide, a potent bioactive compound that shows
multiple pharmacological actions such as anti-inflammatory, antiviral, antioxidant,
hepatoprotective and neuroprotective effects. In addition, it also shows anticancer
effects against various types of tumours along with colon cancer. In this review, we aimed to describe in detail the effect of AG and its analogues in colon cancer by
identifying its possible drug targets. Thereby, it develops a chance to qualify AG as a
novel drug candidate for colon cancer in the near future.